Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Lamictal® (lamotrigine) – New Warning
July 10, 2018 - The FDA approved an update to the Warnings and Precautions section of the Lamictal (lamotrigine) drug label regarding the risk of hemophagocytic lymphohistiocytosis (HLH).
